These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23863947)

  • 41. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.
    Ruskin DN; Ross JL; Kawamura M; Ruiz TL; Geiger JD; Masino SA
    Physiol Behav; 2011 Jul; 103(5):501-7. PubMed ID: 21501628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
    Ouk K; Aungier J; Morton AJ
    Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease.
    Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH
    Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease.
    Cuesta M; Aungier J; Morton AJ
    Neurobiol Dis; 2012 Jan; 45(1):145-55. PubMed ID: 21820053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Ectopic" theta oscillations and interictal activity during slow-wave state in the R6/1 mouse model of Huntington's disease.
    Pignatelli M; Lebreton F; Cho YH; Leinekugel X
    Neurobiol Dis; 2012 Dec; 48(3):409-17. PubMed ID: 22842017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromuscular synapse degeneration without muscle function loss in the diaphragm of a murine model for Huntington's Disease.
    Valadão PAC; Gomes MPSM; Aragão BC; Rodrigues HA; Andrade JN; Garcias R; Joviano-Santos JV; Luiz MA; Camargo WL; Naves LA; Kushmerick C; Cavalcante WLG; Gallacci M; de Jesus ICG; Guatimosim S; Guatimosim C
    Neurochem Int; 2018 Jun; 116():30-42. PubMed ID: 29530757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6/2 Mouse Model of Huntington's Disease.
    Dargaei Z; Liang X; Serranilla M; Santos J; Woodin MA
    Neuroscience; 2019 Apr; 404():130-140. PubMed ID: 30797895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
    Mo C; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.
    Valadão PA; de Aragão BC; Andrade JN; Magalhães-Gomes MP; Foureaux G; Joviano-Santos JV; Nogueira JC; Ribeiro FM; Tapia JC; Guatimosim C
    Eur J Neurosci; 2017 Mar; 45(6):785-796. PubMed ID: 27992085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.
    Southwell AL; Ko J; Patterson PH
    J Neurosci; 2009 Oct; 29(43):13589-602. PubMed ID: 19864571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
    Glynn D; Reim K; Brose N; Morton AJ
    Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
    Spampanato J; Gu X; Yang XW; Mody I
    Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease.
    Wood NI; Glynn D; Morton AJ
    Neurobiol Dis; 2011 Jun; 42(3):427-37. PubMed ID: 21324361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images.
    Zhang J; Peng Q; Li Q; Jahanshad N; Hou Z; Jiang M; Masuda N; Langbehn DR; Miller MI; Mori S; Ross CA; Duan W
    Neuroimage; 2010 Feb; 49(3):2340-51. PubMed ID: 19850133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington's Disease Mice.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2016 Oct; 5(3):285-296. PubMed ID: 27567888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line.
    Brooks SP; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):130-6. PubMed ID: 21763407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An automated and quantitative method to evaluate progression of striatal pathology in Huntington's disease transgenic mice.
    Liang X; Wu J; Egorova P; Bezprozvanny I
    J Huntingtons Dis; 2014; 3(4):343-350. PubMed ID: 25575955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.